Abstract
Objective To examine how the mismatch between telecommuting preference and telecommuting frequency was associated with psychological distress during the COVID-19 pandemic.
Methods Data from 33,302 workers throughout Japan were obtained using an Internet survey. Among 33,302 participants, 20,395 who telecommuted were included in the analysis. Participants’ telecommuting preference and frequency during the COVID-19 pandemic were determined using a questionnaire. Psychological distress was assessed using Kessler 6 (K6).
Results Among participants who did and did not prefer to telecommute, those who telecommuted four or more days per week had an OR of psychological distress of 0.67 (p<0.001) and 1.87 (p=0.001), respectively, compared with those who rarely telecommuted.
Conclusions The association between telecommuting and psychological distress differs depending on telecommuting preference.
Competing Interest Statement
Conflict of Interest: The authors declare no conflicts of interest associated with this manuscript. Acknowledgements The current members of the CORoNaWork Project, in alphabetical order, are as follows: Dr. Yoshihisa Fujino (present chairperson of the study group), Dr. Akira Ogami, Dr. Arisa Harada, Dr. Ayako Hino, Dr. Hajime Ando, Dr. Hisashi Eguchi, Dr. Kazunori Ikegami, Dr. Kei Tokutsu, Dr. Keiji Muramatsu, Dr. Koji Mori, Dr. Kosuke Mafune, Dr. Kyoko Kitagawa, Dr. Masako Nagata, Dr. Mayumi Tsuji, Ms. Ning Liu, Dr. Rie Tanaka, Dr. Ryutaro Matsugaki, Dr. Seiichiro Tateishi, Dr. Shinya Matsuda, Dr. Tomohiro Ishimaru, and Dr. Tomohisa Nagata. All members are affiliated with the University of Occupational and Environmental Health, Japan.
Funding Statement
Funding Sources This study was supported and partly funded by the University of Occupational and Environmental Health, Japan; General Incorporated Foundation (Anshin Zaidan); The Development of Educational Materials on Mental Health Measures for Managers at Small-sized Enterprises; Health, Labour and Welfare Sciences Research Grants; Comprehensive Research for Women's Healthcare (H30-josei-ippan-002); Research for the Establishment of an Occupational Health System in Times of Disaster (H30-roudou-ippan-007), scholarship donations from Chugai Pharmaceutical Co., Ltd., the Collabo-Health Study Group, and Hitachi Systems, Ltd.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the ethics committee of the University of Occupational and Environmental Health, Japan (reference No. R2-079 and R3-006).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding Sources This study was supported and partly funded by the University of Occupational and Environmental Health, Japan; General Incorporated Foundation (Anshin Zaidan); The Development of Educational Materials on Mental Health Measures for Managers at Small-sized Enterprises; Health, Labour and Welfare Sciences Research Grants; Comprehensive Research for Women’s Healthcare (H30-josei-ippan-002); Research for the Establishment of an Occupational Health System in Times of Disaster (H30-roudouippan-007), scholarship donations from Chugai Pharmaceutical Co., Ltd., the Collabo-Health Study Group, and Hitachi Systems, Ltd.
Conflict of Interest: The authors declare no conflicts of interest associated with this manuscript.
Ethical approval: This study was approved by the ethics committee of the University of Occupational and Environmental Health, Japan (reference No. R2-079 and R3-006).
Data Availability
Data not available due to ethical restrictions
